"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Descriptor ID |
D009154
|
MeSH Number(s) |
G05.365.590
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 12 | 31 | 43 |
1995 | 15 | 26 | 41 |
1996 | 24 | 22 | 46 |
1997 | 26 | 16 | 42 |
1998 | 23 | 37 | 60 |
1999 | 14 | 34 | 48 |
2000 | 27 | 41 | 68 |
2001 | 15 | 48 | 63 |
2002 | 21 | 49 | 70 |
2003 | 20 | 77 | 97 |
2004 | 19 | 61 | 80 |
2005 | 23 | 79 | 102 |
2006 | 25 | 71 | 96 |
2007 | 27 | 56 | 83 |
2008 | 25 | 68 | 93 |
2009 | 25 | 69 | 94 |
2010 | 34 | 66 | 100 |
2011 | 35 | 83 | 118 |
2012 | 45 | 69 | 114 |
2013 | 42 | 69 | 111 |
2014 | 43 | 78 | 121 |
2015 | 47 | 89 | 136 |
2016 | 39 | 93 | 132 |
2017 | 34 | 77 | 111 |
2018 | 41 | 105 | 146 |
2019 | 47 | 67 | 114 |
2020 | 26 | 88 | 114 |
2021 | 24 | 81 | 105 |
2022 | 8 | 79 | 87 |
2023 | 2 | 79 | 81 |
2024 | 10 | 30 | 40 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nat Commun. 2024 Jul 11; 15(1):5837.
-
Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations. Sci Rep. 2024 Jul 08; 14(1):15744.
-
Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous FOXN1 Mutations. Immunohorizons. 2024 Jul 01; 8(7):492-499.
-
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 Jun 18; 14(1):99.
-
Molecular Profiling and the Interaction of Somatic Mutations with Transcriptomic Profiles in Non-Melanoma Skin Cancer (NMSC) in a Population Exposed to Arsenic. Cells. 2024 Jun 18; 13(12).
-
The clock-like accumulation of germline and somatic mutations can arise from the interplay of DNA damage and repair. PLoS Biol. 2024 Jun; 22(6):e3002678.
-
STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia. Haematologica. 2024 Jun 01; 109(6):1825-1835.
-
Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC. J Thorac Oncol. 2024 Jun; 19(6):877-882.
-
Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO Precis Oncol. 2024 Jun; 8:e2400026.
-
Survival outcomes and molecular drivers of testicular cancer in hispanic men. Urol Oncol. 2024 Sep; 42(9):293.e1-293.e7.